Search filters

List of works by Peter B. Berger

A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

scientific article published in September 2005

Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials

scientific article (publication date: 15 May 2005)

Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding

scientific article published in March 2009

Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance

scientific article

Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial

scientific article published in November 2008

Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

scientific article published in July 2011

Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISM

scientific article published in April 2009

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

scientific article (publication date: 20 April 2006)

Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial

scientific article

Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention

scientific article published in September 2004

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

scientific article (publication date: 20 November 2002)

Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial

scientific article published in May 2009

Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)

scientific article (publication date: August 2003)

Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials

scientific article

Is there a clinically significant interaction between calcium channel antagonists and clopidogrel?: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial

scientific article

Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial

scientific article (publication date: 26 August 2003)

Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial

scientific article published in October 2007

Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting

scientific article (publication date: 2 January 2002)

Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention

scientific article published on 9 February 2006

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

scientific article (publication date: 15 May 2007)

Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial

scientific article published on 29 August 2011

Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trial

scientific article (publication date: July 2007)

Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial

scientific article published on 17 November 2009

Smoking, clopidogrel, and mortality in patients with established cardiovascular disease

scientific article

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial

scientific article published on March 2011

The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial

scientific article published on 21 February 2008

The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial

scientific article published in May 2005

The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study

article

The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis

scientific article

Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)

scientific article (publication date: October 2003)

Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival

article by Albert W Chan et al published October 2003 in Journal of the American College of Cardiology

Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction

scientific article (publication date: 27 June 2002)

Variability in platelet responsiveness to clopidogrel among 544 individuals.

scientific article published on January 2005

Paulina is supported by:

About Paulina

Help